论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
基于生物分子自组装的超分子纳米酶用于癌症治疗
Authors Hu P, Zheng J, Wang H, Li Y, Ye T, Li Q, Lan X, Liu C, Liu C
Received 27 September 2024
Accepted for publication 10 January 2025
Published 15 February 2025 Volume 2025:20 Pages 2043—2057
DOI https://doi.org/10.2147/IJN.S496831
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Kamakhya Misra
Pengcheng Hu,1 Jilu Zheng,1 Hongjuan Wang,1 Yongxin Li,2 Tao Ye,1,3 Quanjun Li,1 Xiaopeng Lan,1 Chunzhao Liu,2 Chunlei Liu1
1Department of Urology, Department of Primary Healthcare, Department of Cardiology, Qingdao Central Hospital, University of Health and Rehabilitation Sciences, Qingdao, 266071, People’s Republic of China; 2College of Materials Science and Engineering, Qingdao University, Qingdao, 266071, People’s Republic of China; 3School of Clinical Medicine, Shandong second Medical University, Weifang, Shandong, 261053, People’s Republic of China
Correspondence: Chunlei Liu; Chunzhao Liu, Email liuchunlei1969@126.com; czliu@qdu.edu.cn
Abstract: Natural enzyme systems possess extraordinary functions and characteristics, making them highly appealing for use in eco-friendly technologies and innovative cancer treatments. However, their inherent instability and structural complexity often limit their practical applications, leading to the exploration of biomolecular nanozyme alternatives. Supramolecular nanozymes, constructed using self-assembly techniques and various non-covalent interactions, have emerged as a promising solution. Amino acids, peptides, and protein motifs offer flexible building blocks for constructing these nanozymes. Importantly, the well-defined structural regulation mechanisms of biomolecular nanozymes, along with their unique properties as fundamental biological modules in living systems—such as selectivity, permeability, retention, and biocompatibility—present new opportunities for cancer therapy. This review highlights recent advances in supramolecular self-assembled nanozymes, including peroxidases, oxidases, catalases, superoxide dismutases, and other nanozyme systems, as building blocks for tumor therapy. Additionally, it discusses precise functional modulation through supramolecular non-covalent interactions and their therapeutic applications in targeting the tumor microenvironment. These studies provide valuable insights that may inspire the design of novel supramolecular nanozymes with enhanced catalytic selectivity, biocompatibility, and tumor-killing efficacy.
Keywords: supramolecular nanozymes, self-assembly, biomolecular, tumor therapy